A similar result was obtained from the Transwell assay (Figs. 6G and 6H): cotransfection of TPM3 and miR-29b-2-5p mimics attenuated the inhibitory effect of miR-29b-2-5p mimic treatment on the migration and invasion of glioma cell lines after miR-29b-2-5p mimic treatment. Here, TPM3 is linked to central nervous system cancer.